Northside Hospital Research Program

Find Open Clinical Trials

Return to Search

Phase II trial evaluating the Efficacy and Safety of Sargramostim Post Infusion of T -Replete HLA Mismatched Peripheral Blood Haploidentical Hematopoietic Stem Cells with Post Transplant Cyclophosphamide

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT04237623
Protocol Number
NSH1246
Phase
II
Management Group
BMT Program
Oncology Group
BMT Oncology Group
Disease Sites
Other Hematopoietic
Principal Investigator
Melhem Solh
Scope
Local
Participating Institutions
Northside Hospital - Atlanta (BMT)
Return to Search

Want to learn more?

For further information on our clinical trials, please call the Northside Hospital Research Program at (404) 303-3355 or

Email Us

For further information on our clinical trials, please contact the Northside Hospital Research Program at
(404) 303-3355 or

Call Us
Email Us